Atia Vision

company

About

Atia Medical focuses on advancing eye care through the innovation of ophthalmic devices, diagnostics, and pharmaceuticals.

  • 1 - 10

Details

Last Funding Type
Series C
Last Funding Money Raised
$10M
Industries
Biotechnology,Health Care,Medical,Medical Device
Founded date
Jan 1, 2012
Number Of Employee
1 - 10
Operating Status
Active

Atia Medical is a medical device company focusing on advancing eye care through the innovation of ophthalmic devices, diagnostics, and pharmaceuticals. The company is focused on developing advanced solutions that get to market faster, reduce risk, increase impact, and forge a path toward a world where all people are able to lead longer healthier lives. They improving patient outcomes through the development of a modular presbyopia-correcting accommodating intraocular lens.

Atia Vision modular intraocular lens technology features an accommodating base responsive to the ciliary muscles, simulating the natural mechanism of the eye and fixed lens element that allows for subsequent refractive correction. The company's unique technology enables natural accommodation, utilizing the ciliary muscles of the eye and providing for subsequent refractive correction, to restore the full range of functional vision for cataract patients.

Atria Vision was founded in 2012 and is headquartered in Campbell, California, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$55M
Atia Vision has raised a total of $55M in funding over 2 rounds. Their latest funding was raised on Aug 2, 2022 from a Series E round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 2, 2022 Series E $42M 1 Detail
Dec 10, 2018 Series C $10M 1 Detail
May 12, 2015 Series B $3M 1 Medvance Incubator Partners Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Atia Vision is funded by 2 investors. Picard Angst MedTech Fund and Medvance Incubator Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Picard Angst MedTech Fund Series E
Medvance Incubator Partners Series C